Seasonal flu is a respiratory illness, which affects the lungs and airways and is easily spread from person to person. It occurs every year, usually in the winter, which is why it’s also known as ‘seasonal’ flu.
The purpose of this clinical research study is to develop a better vaccine to prevent seasonal flu infection.
mRNA vaccines aim to teach the body how to make a specific protein that may potentially help the immune system prevent or treat certain diseases. The hope is that the vaccine trains your immune system cells to “remember” these proteins and helps your body quickly protect against the strain of infection if exposed in the future. This new vaccine is being compared to the standard (usual) vaccines.
SHARE are currently recruiting potential participants for this study.
The study involves:
- 2 Visits to the study site that may include questions about your health, physical examination, blood tests, nasopharyngeal swabs and other medical tests.
- Completing an electronic study diary (eDiary) twice a week to feedback on how you feel.
Please contact the SHARE Study team on [email protected] Or call 01382 383235.
